The James Paget Hospital in Great Yarmouth has now become the fifth site in the East of England and the sixth site nationally ...

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England. In a ...

A consultant medical oncologist from Sheffield Teaching Hospitals NHS Foundation Trust has become the new President of the ...

The Personalised Breast Cancer Programme (PBCP) is now available at James Paget University Hospital in Gorleston. The PBCP uses whole genome sequencing to analyse tumour DNA and identify genetic ...

The public health system in England offered me palliative care. It was a death sentence I wasn't willing to accept. I wasn't ready to leave behind my six children: Matt, 35; Will, 24; Hannah, 19; ...

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

The global oncology market, including breakthrough treatments, is experiencing substantial growth, with revenues projected to reach hundreds of billions of dollars in the coming years. Several factors ...

Manufacturing companies are particularly attentive to drugs designated as breakthrough therapies due to the accelerated market access and higher returns on investment. Breakthrough therapy drugs often ...

An artificial intelligence tool outperforms human readers in diagnostic mammography but shows lower accuracy at the lesion ...

WE are living in what experts are calling a “golden age” of cancer treatment. New medicines are being developed every year, ...